- 全部删除
您的购物车当前为空
DX3-213B 是一种高效的、口服具有活力的氧化磷酸化 (OXPHOS) 复合物 I 抑制剂,其 IC50 值为 3.6 nM。DX3-213B 能够阻断 ATP 的生成 (IC50: 11 nM),抑制 MIA PaCa-2 细胞生长 (GI50: 11 nM)。DX3-213B 能够用于研究胰腺癌。


为众多的药物研发团队赋能,
让新药发现更简单!
DX3-213B 是一种高效的、口服具有活力的氧化磷酸化 (OXPHOS) 复合物 I 抑制剂,其 IC50 值为 3.6 nM。DX3-213B 能够阻断 ATP 的生成 (IC50: 11 nM),抑制 MIA PaCa-2 细胞生长 (GI50: 11 nM)。DX3-213B 能够用于研究胰腺癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 662 | In stock | |
| 5 mg | ¥ 1,650 | In stock | |
| 10 mg | ¥ 2,650 | In stock | |
| 25 mg | ¥ 4,970 | In stock | |
| 50 mg | ¥ 6,880 | In stock | |
| 100 mg | ¥ 9,270 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,730 | In stock |
DX3-213B 相关产品
| 产品描述 | DX3-213B is a potent, orally active inhibitor of oxidative phosphorylation (OXPHOS) complex I with an IC50 of 3.6 nM. DX3-213B blocks ATP production (IC50: 11 nM) and inhibits the growth of MIA PaCa-2 cells (GI50: 11 nM). DX3-213B can be used to study pancreatic cancer. |
| 靶点活性 | OXPHOS complex I:3.6 nM |
| 分子量 | 478.57 |
| 分子式 | C20H28F2N2O5S2 |
| CAS No. | 2749555-66-4 |
| Smiles | CC(C)S(=O)(=O)c1ccc(cc1)S(=O)(=O)N1CCC[C@H](C1)C(=O)N1CCC(F)(F)CC1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 112.5 mg/mL (235.1 mM), Sonication and heating to 60℃ are recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (8.36 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容